Editor's note: This article was originally distributed as a view-only briefing as part of the ExpertREACT service by VacZine Analytics.

In terms of current meningococcal disease burden, the statistics related to serogroup B are convincing when making arguments in support of new meningitis vaccines........... CONTINUED......